Immunofluorescence staining of cleaved caspase-3 (CC3) on GB tumour xenograft sections showed significantly higher CC3 levels in tumours receiving combined IR and mubritinib compared to either treatment alone (Fig. 5O). The gene discussed is CASP3; the disease is neoplasm.